After finishing at $7.99 in the prior trading day, Avid Bioservices Inc (NASDAQ: CDMO) closed at $8.30, up 3.88%. In other words, the price has increased by $+0.31 from its previous closing price. On the day, 574880 shares were traded.
Ratios:
Our goal is to gain a better understanding of CDMO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 1.06.
On March 14, 2023, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 12 when Kwietniak Matthew R. sold 274 shares for $6.77 per share. The transaction valued at 1,855 led to the insider holds 19,829 shares of the business.
Hart Daniel R sold 2,408 shares of CDMO for $14,857 on Jan 10. The Chief Financial Officer now owns 79,305 shares after completing the transaction at $6.17 per share. On Jan 10, another insider, Ziebell Mark R, who serves as the V. P., General Counsel of the company, sold 1,346 shares for $6.17 each. As a result, the insider received 8,305 and left with 63,269 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDMO now has a Market Capitalization of 524.89M and an Enterprise Value of 688.75M. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.72 while its Price-to-Book (P/B) ratio in mrq is 2.86. Its current Enterprise Value per Revenue stands at 4.89 whereas that against EBITDA is 1.14k.
Stock Price History:
Over the past 52 weeks, CDMO has reached a high of $21.05, while it has fallen to a 52-week low of $4.07. The 50-Day Moving Average of the stock is 6.85, while the 200-Day Moving Average is calculated to be 9.68.
Shares Statistics:
The stock has traded on average 1.43M shares per day over the past 3-months and 894.8k shares per day over the last 10 days, according to various share statistics. A total of 62.69M shares are outstanding, with a floating share count of 62.58M. Insiders hold about 1.05% of the company’s shares, while institutions hold 91.20% stake in the company. Shares short for CDMO as of Feb 15, 2024 were 5.65M with a Short Ratio of 3.94, compared to 5.54M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.93% and a Short% of Float of 10.67%.
Earnings Estimates
Its stock is currently analyzed by 4 different market analysts. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.03 and a low estimate of -$0.07, while EPS last year was $0.01. The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.02 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.23 and -$0.3 for the fiscal current year, implying an average EPS of -$0.26. EPS for the following year is -$0.03, with 4 analysts recommending between $0.03 and -$0.07.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for CDMO’s current fiscal year. The highest revenue estimate was $140.84M, while the lowest revenue estimate was $137M, resulting in an average revenue estimate of $138.9M. In the same quarter a year ago, actual revenue was $149.27M, down -6.90% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $166.31M in the next fiscal year. The high estimate is $175M and the low estimate is $160.01M. The average revenue growth estimate for next year is up 19.70% from the average revenue estimate for this year.
